HempStreet in strategic partnership with Israeli Femtech Co Gynica
17 May 2022 | News
The partnership is aimed to bolster the combined R&D efforts to improve women’s health with cannabinoid-based phytomedicine
Image Credit: Shutterstock
HempStreet has partnered with Gynica, an R&D company based out of Israel focused on changing the culture of gynaecological treatment through clinically proven, cannabinoid-based solutions. The partnership will benefit the companies to strengthen their R&D capabilities and develop clinically-proven, robust phytopharmaceutical products to improve menstrual health and tackle other mass ailments.
Both the companies will co-develop medical products for the Indian market to tackle ailments specifically related to women’s health.
